Literature DB >> 29621847

How do general practitioners conceptualise self-harm in their older patients? A qualitative study

Anne PF Wand1, Carmelle Peisah2, Brian Draper3, Henry Brodaty4.   

Abstract

Background and objectives: Little is known about how general practitioners (GPs) conceptualise self-harm in older people. The aim of this study was to explore GPs' understanding of the reasons for recent self-harm in an older patient. Method: Short questionnaires were sent to the GPs of patients aged 80 years or older who had recently self-harmed and were participants in a qualitative study about self-harm. Questions evaluated GPs’ understanding of the self-harm. Thematic analysis was used to identify and analyse themes.
Results: Thirteen GP responses were analysed. GPs could identify multiple factors contributing to self-harm in their patients but did not see a role for themselves in addressing these issues. They feared repetition of self-harm if these underlying contributory factors, including depression, did not change. Discussion: Targeted education and practical options for GPs regarding management of the issues underlying self-harm in older people are needed. Families and carers may be underused allies in management. These strategies may serve to counter therapeutic nihilism and clinician isolation.

Entities:  

Mesh:

Year:  2018        PMID: 29621847     DOI: 10.31128/AFP-08-17-4311

Source DB:  PubMed          Journal:  Aust J Gen Pract


  2 in total

1.  Role of primary care in supporting older adults who self-harm: a qualitative study in England.

Authors:  M Isabela Troya; Carolyn A Chew-Graham; Opeyemi Babatunde; Bernadette Bartlam; Faraz Mughal; Lisa Dikomitis
Journal:  Br J Gen Pract       Date:  2019-10-31       Impact factor: 5.386

2.  Role of the GP in the management of patients with self-harm behaviour: a systematic review.

Authors:  Faraz Mughal; M Isabela Troya; Lisa Dikomitis; Carolyn A Chew-Graham; Nadia Corp; Opeyemi O Babatunde
Journal:  Br J Gen Pract       Date:  2020-04-30       Impact factor: 5.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.